1504
X.-s. Wu et al.
LETTER
(2) (a) Xia, Y.; Yang, Z.-Y.; Xia, P.; Bastow, K. F.; Kuo, S.-C.;
Li, K.-H. J. Med. Chem. 1998, 41, 1155. (b) Freyer, A. J.;
Abu Zarga, M. H.; Firdous, S.; Shamma, M. J. Nat. Prod.
1987, 50, 684.
(3) (a) Gupta, S.; Das, L.; Datta, A. B.; Poddar, A.; Janik, M. E.;
Bhattacharrya, B. Biochemistry 2006, 45, 6467.
R
R
R
R
R
O–
O
O
+
CH2
CH2
CH2
R
(b) Charlton, J. L. J. Nat. Prod. 1998, 61, 1447.
8
9
7
(4) (a) Damu, A. G.; Kuo, P.-C.; Shi, L.-S.; Li, C.-Y.; Kuoh,
C.-S.; Wu, P.-L.; Wu, T.-S. J. Nat. Prod. 2005, 68, 1071.
(b) Wei, L.; Shi, Q.; Bastow, K. F.; Brossi, A.; Morris-
Natschke, S. L.; Nakagawa-Goto, K.; Wu, T.-S.; Pan, S.-L.;
Teng, C.-M.; Lee, K.-H. J. Med. Chem. 2007, 50, 3674.
(c) Stark, D.; Lykkeberg, A. K.; Christensen, J.; Budnik, B.
A.; Abe, F.; Jaroszewski, J. W. J. Nat. Prod. 2002, 65, 1299.
(5) Bilgic, S.; Bilgic, O.; Bueyuekkidan, B.; Guenduez, M.
J. Chem. Res. 2007, 2, 76.
R
R
O
O
O
R
R
CH2
R
R
C
R
H2
O
R
CH2
C
H2
B
A
(6) Chauhan, M. S.; Mckinon, D. M. Can. J. Chem. 1981, 59,
2223.
Figure 2
(7) (a) Weinert, E.; Dondi, R.; Colloredo-Melz, S.;
Frankenfield, K. N.; Mitchell, C. H.; Freccero, M.; Rokita,
S. E. J. Am. Chem. Soc. 2006, 128, 11940. (b) Gardner, P.
D.; Sarrafizadeh, H. R.; Brandon, R. L. J. Am. Chem. Soc.
1959, 81, 5515.
B–
R
OH
R
(8) (a) Lin, S.-Z.; Chen, Q.-A.; You, T.-P. Synlett 2007, 2101.
(b) Lin, S.-Z.; You, T.-P. Tetrahedron 2008, 64, 9906.
(9) Synthesis of the Dimer of 10-Methylene-9-
phenanthrones 1a–g – General Procedure
HO+
R
To a stirred suspension of the 9-phenanthrol (1 mmol) in
MeOH (10mL, 9d was in THF–MeOH = 4:1), L-proline (6
mg, 0.05 mmol) and 36% aq formaldehyde (0.1 mL, 1.2
mmol) were added. The mixture was stirred at r.t. for 2–4 h.
The reaction product was evaporated under vacuum. The
residue was purified by flash column chromatography on
SiO2, eluting with PE–EtOAc, to produce the dimer of 10-
methylene-9-phenanthrones.
R
R
O
R
R
OH
R
HO
HO
R
R
(10) Selective Spectroscopic Data of the Dimer of
10-Methylene-9-phenanthrones
R
R
10
Compound 1a: 1H NMR (300 MHz, CDCl3): d = 2.29 (m, 1
H), 2.54–2.60 (m, 2 H), 2.92 (m, 1 H), 3.72 (s, 3 H), 3.74 (s,
3 H), 3.77 (s, 3 H), 3.87 (s, 3 H), 3.89 (s, 3 H), 3.91 (s, 3 H),
3.96 (s, 6 H), 4.00 (s, 3 H), 4.02 (s, 3 H), 4.03 (s, 3 H), 4.06
(s, 3 H), 6.83 (s, 1 H), 7.11 (s, 1 H), 7.26 (s, 1 H), 7.68 (s, 1
H). 13C NMR (75 MHz, CDCl3): d = 20.6, 32.8, 55.9, 55.9,
56.1, 56.3, 61.0, 61.1, 61.1, 61.2, 61.2, 61.3, 61.4, 61.5, 83.1,
97.4, 98.0, 103.6, 105.2, 107.7, 113.1, 116.3, 117.7, 121.5,
123.1, 124.9, 132.4, 140.3, 142.3, 142.5, 146.7, 151.7,
151.8, 152.0, 152.2, 152.3, 152.4, 153.2, 153.6, 197.6.
HRMS–FAB: m/z [M + H]+ calcd for C42H44O14: 773.2809;
found: 773.2810. Anal. Calcd for C42H44O14: C, 65.28; H,
5.74; O, 28.98. Found: C, 65.41; H, 5.72; O, 28.92.
Compound 1b: 1H NMR (300 MHz, CDCl3): d = 2.27 (m, 1
H), 2.51 (m, 1 H), 2.82 (m, 1 H), 3.04 (m, 1 H), 3.83 (s, 3 H),
3.93 (s, 3 H), 3.96 (s, 3 H), 3.99 (s, 3 H), 4.00 (s, 3 H), 4.04
(s, 3 H), 4.10 (s, 3 H), 4.11 (s, 3 H), 4.14 (s, 3 H), 7.14 (s, 1
H), 7.24 (s, 1 H), 7.29 (s, 1 H), 7.36 (s, 1 H), 7.42 (s, 1 H),
7.52 (s, 1 H), 7.83 (m, 3 H). 13C NMR (75 MHz, CDCl3):
d = 19.6, 34.1, 55.8, 55.8, 56.0, 56.1, 56.2, 56.2, 56.3, 56.5,
82.3, 102.5, 103.1, 103.3, 103.9, 104.7, 106.9, 107.4, 108.7,
109.2, 119.7, 119.9, 121.5, 122.5, 124.6, 126.1, 131.6,
133.8, 146.6, 147.1, 148.7, 148.9, 149.0, 149.1, 149.2,
149.9, 154.5, 198.1. HRMS–FAB: m/z [M + H]+ calcd for
C38H36O10: 653.2387; found: 653.2389. Anal. Calcd for
C38H36O10: C, 69.93; H, 5.56; O, 24.51. Found: C, 69.77; H,
5.50; O, 24.60.
Scheme 4 Michael addition of 9-phenanthrol to10-methylene-9-
phenanthrone
In conclusion, using proline as a recoverable catalyst, we
have conveniently synthesized
a
new class of
spirophenanthrones from 9-phenanthrols. Further biolog-
ical activity testing of these compounds is in progress.
Supporting Information for this article is available online at
Acknowledgment
Project was supported by the National Natural Science Foundation
of China (No. 20472077). In addition, we thank the referees for very
valuable advice.
References and Notes
(1) (a) Choi, Y.-W.; Takamatsu, S.; Khan, S. I.; Srinivas, P. V.;
Ferreira, D.; Zhao, J. J. Nat. Prod. 2006, 69, 356. (b) Chen,
M.; Kilgore, N.; Lee, K.-H.; Chen, D.-F. J. Nat. Prod. 2006,
69, 1697.
Compound 1c: 1H NMR (300 MHz, CDCl3): d = 2.27 (m, 1
H), 2.54 (m, 1 H), 2.60 (m, 1 H), 2.91 (m, 1 H), 3.89 (s, 3 H),
3.94 (s, 3 H), 3.99 (s, 3 H), 4.02 (s, 3 H), 6.03 (d, 2 H), 6.14
Synlett 2009, No. 9, 1501–1505 © Thieme Stuttgart · New York